Literature DB >> 4067255

Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis. A clinicopathological study.

Y F Liaw, S S Yang, T J Chen, C M Chu.   

Abstract

During a 6-year (mean 24.5 months) follow-up study of 237 HBeAg-positive patients with biopsy-verified chronic type B hepatitis, 199 episodes of acute exacerbation (SGPT greater than 300 IU/l) were observed in 148 patients. The clinical and laboratory findings of these acute exacerbations were less severe than classic acute viral hepatitis (P less than 0.001) but with remarkable overlapping. The main histological changes of acute exacerbations were those of lobular hepatitis, even with bridging hepatic necrosis which predicted subsequent HBeAg clearance. Anti-HBc IgM was positive in 14.4% of the exacerbations. All of these findings made acute exacerbation of chronic type B hepatitis indistinguishable from acute viral hepatitis aside from chronic clinical history. Hepatitis A virus, delta agent and possibly non-A, non-B virus(es) were responsible for some of the episodes of clinical exacerbations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067255     DOI: 10.1016/s0168-8278(85)80050-7

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Investigation of HBV infection status in anti-HBe Chinese patients with chronic hepatitis by in situ hybridization assay.

Authors:  Y Y Zhang; Y K Wang; L J Hao; Y C Zhu
Journal:  J Tongji Med Univ       Date:  1989

Review 2.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

3.  Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.

Authors:  Mayur Brahmania; Manuel Lombardero; Bettina E Hansen; Norah A Terrault; Anna S Lok; Robert P Perrillo; Steven H Belle; Adrian M Di Bisceglie; Jordan J Feld; William M Lee; Michael W Fried; Harry L A Janssen
Journal:  Clin Gastroenterol Hepatol       Date:  2019-02-08       Impact factor: 11.382

Review 4.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B.

Authors:  Corinna Jen-Hui Pan; Hui-Lin Wu; Stephanie Fang-Tzu Kuo; Jia-Horng Kao; Tai-Chung Tseng; Chen-Hua Liu; Pei-Jer Chen; Chun-Jen Liu; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2011-07-16       Impact factor: 6.047

6.  HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B.

Authors:  Yun-Fan Liaw
Journal:  Hepatol Int       Date:  2009-06-24       Impact factor: 6.047

7.  Role of viral factors in the natural course and therapy of chronic hepatitis B.

Authors:  Jia-Horng Kao
Journal:  Hepatol Int       Date:  2007-10-12       Impact factor: 6.047

Review 8.  Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

Authors:  Marc G Ghany; Jordan J Feld; Kyong-Mi Chang; Henry L Y Chan; Anna S F Lok; Kumar Visvanathan; Harry L A Janssen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-02-10

9.  Etiology of acute exacerbation in patients with severe chronic active hepatitis by in situ HBVDNA hybridization technique.

Authors:  Y Y Zhang; Y K Wang; H Q Sheng; L Li; L J Hao; Y D Zhang; G Z Hou
Journal:  J Tongji Med Univ       Date:  1990

10.  Nucleotide sequence analysis of the precore region in patients with spontaneous reactivation of chronic hepatitis B.

Authors:  T Laskus; J Rakela; M J Tong; D H Persing
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.